Follow
CAROLINA MÉNDEZ BLANCO
CAROLINA MÉNDEZ BLANCO
Predoctoral researcher at the Institute of Biomedicine (IBIOMED)-University of León
Verified email at unileon.es
Title
Cited by
Cited by
Year
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
C Méndez-Blanco, F Fondevila, A García-Palomo, J González-Gallego, ...
Experimental & molecular medicine 50 (10), 1-9, 2018
2602018
Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy
N Prieto‐Domínguez, R Ordóñez, A Fernández, C Méndez‐Blanco, ...
Journal of pineal research 61 (3), 396-407, 2016
1332016
Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy
N Prieto-Domínguez, C Méndez-Blanco, S Carbajo-Pescador, ...
Oncotarget 8 (53), 91402, 2017
812017
Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
F Fondevila, C Méndez-Blanco, P Fernández-Palanca, ...
Experimental & molecular medicine 51 (9), 1-15, 2019
692019
Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: a systematic review
P Fernández-Palanca, F Fondevila, C Méndez-Blanco, MJ Tuñón, ...
Nutrients 11 (12), 2875, 2019
572019
Melatonin as an antitumor agent against liver cancer: an updated systematic review
P Fernández-Palanca, C Méndez-Blanco, F Fondevila, MJ Tuñón, ...
Antioxidants 10 (1), 103, 2021
342021
Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells
C Méndez-Blanco, F Fondevila, P Fernández-Palanca, A García-Palomo, ...
Cancers 11 (12), 1984, 2019
322019
Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: A systematic review with meta-analysis
C Méndez-Blanco, P Fernández-Palanca, F Fondevila, ...
Therapeutic Advances in Medical Oncology 13, 1758835920987071, 2021
212021
Association of FOXO3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: a systematic review with meta-analysis
F Fondevila, P Fernandez-Palanca, C Mendez-Blanco, T Payo-Serafin, ...
Cancers 13 (21), 5349, 2021
122021
Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation
P Fernández-Palanca, T Payo-Serafín, B San-Miguel, C Méndez-Blanco, ...
Acta Pharmacologica Sinica 44 (5), 1066-1082, 2023
82023
Neuropilin-1 as a potential biomarker of prognosis and invasive-related parameters in liver and colorectal cancer: A systematic review and meta-analysis of human studies
P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ...
Cancers 14 (14), 3455, 2022
82022
Autophagy-related chemoprotection against sorafenib in human hepatocarcinoma: Role of FOXO3 upregulation and modulation by regorafenib
F Fondevila, C Mendez-Blanco, P Fernandez-Palanca, T Payo-Serafin, ...
International Journal of Molecular Sciences 22 (21), 11770, 2021
82021
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
P Fernández-Palanca, T Payo-Serafín, C Méndez-Blanco, B San-Miguel, ...
Clinical and Molecular Hepatology 29 (2), 293, 2023
32023
Mendez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (vol …
C Mendez-Blanco, F Fondevila, P Fernandez-Palanca, A Garcia-Palomo, ...
Cancers 15 (23), 2023
2023
Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma …
C Méndez-Blanco, F Fondevila, P Fernández-Palanca, A García-Palomo, ...
Cancers 15 (23), 5668, 2023
2023
Relevance of hypoxia-inducible factor 1 alpha in hepatocellular carcinoma: clinical and pre-clinical analysis
T Payo-Serafín, P Fernández-Palanca, C Méndez-Blanco, ...
Journal of Hepatology 78, S554-S555, 2023
2023
Role of autophagy-mediated neuropilin-1 degradation on lenvatinib efficacy in human hepatocarcinoma
P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ...
Journal of Hepatology 77, S639-S640, 2022
2022
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies …
P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ...
s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022
2022
HIF-1 alpha ON PROGNOSIS, RECURRENCE AND ACQUISITION OF RESISTANCE TO SORAFENIB IN HEPATOCARCINOMA
C Mendez-Blanco, F Fondevila, P Fernandez-Palanca, F Jorquera, ...
HEPATOLOGY 74, 300A-300A, 2021
2021
HIF-2 alpha AS A NOVEL PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET ASSOCIATED TO SORAFENIB RESISTANCE IN HEPATOCARCINOMA
P Fernandez-Palanca, C Mendez-Blanco, F Fondevila, F Jorquera, ...
HEPATOLOGY 74, 301A-301A, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20